FdaApplication
NDA 022574
Identifiers
- fda_app_no: NDA022574
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER HEALTHCARE PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2010-12-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SAFYRAL | DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM | 3MG,N/A;0.03MG,N/A;0.451MG,0.451MG | TABLET;ORAL |
1 product